PDF herunterladen
Int J Angiol
DOI: 10.1055/a-2536-9161
Original Article

Left Ventricular Assist Device in the Management of Heart Failure: A Single-Center Experience

Sam Karem
1   MS3 at University of Kentucky College of Medicine, Lexington, Kentucky
,
Rajasekhar S.R. Malyala
2   University of Kentucky Cardiovascular and Thoracic Surgery, Lexington, Kentucky
,
Sibu Saha
3   University of Kentucky Healthcare System, Lexington, Kentucky
› Institutsangaben
Funding The project described was supported by the NIH National Center for Advancing Translational Sciences through grant number UL1TR001998.
› Weitere Informationen
   Lizenzen und Reprints

Abstract

Background Heart failure is a prevalent health care issue in the United States. While most cases of heart failure can be managed medically, intractable cases benefit from a left ventricular assist device (LVAD).

Aim The aim of this study is to review the outcomes of LVAD therapy at the University of Kentucky.

Materials and Methods Data received from University of Kentucky Hospital. We received Institutional Review Board approval to review patient records admitted for LVAD implantation from January 1, 2017, to December 31, 2021.

Results After reviewing records, we had 127 eligible LVAD patients with an age range of 18 to 83 years, with 87% of recipients being white, 12.5% being black, 81% male, and 19% female. Results show the average length of admission for patients receiving LVAD is 41 days. Quality of life is reported using the New York Heart Association (NYHA) classification at follow-up, which shows 6 patients in Class I, 52 patients progressing to Class II, 21 patients to class III; other patients were deceased before discharge or did not go below class IV heart failure. Prior to 2021, there were 105 patients and 65 patients were alive at 2 years follow-up, and 18 out of 23 patients who received LVAD after 2021 are still living. For postoperative complications, 26% developed stroke, 24.4% developed gastrointestinal bleeding, 26% developed renal failure, 44.8% developed respiratory failure, 37% developed driveline infection, 14.2% developed right ventricular dysfunction/failure, and 20.4% developed an LVAD complication.

Conclusion LVAD has been implemented to manage advanced heart failure and improve quality of life.

Keywords

LVAD - heart failure - left ventricular assist device


Publikationsverlauf

Artikel online veröffentlicht:
07. März 2025

© 2025. International College of Angiology. This article is published by Thieme.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Chahine J, Alvey H. Left Ventricular Failure. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022
    Suche in Google Scholar
  • 2 Symalla T, Jeevanandam V. Choosing the appropriate left ventricular assist device for your patient. Indian J Thorac Cardiovasc Surg 2020; 36 (Suppl. 02) 256-264
    CrossrefPubMedSuche in Google Scholar
  • 3 Rose EA, Gelijns AC, Moskowitz AJ. et al; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001; 345 (20) 1435-1443
    CrossrefPubMedSuche in Google Scholar
  • 4 Ben Gal T, Ben Avraham B, Milicic D. et al. Guidance on the management of left ventricular assist device (LVAD) supported patients for the non-LVAD specialist healthcare provider: executive summary. Eur J Heart Fail 2021; 23 (10) 1597-1609
    CrossrefPubMedSuche in Google Scholar
  • 5 Shafii A, Liao K, Ghanta RK. Commentary: Guidance during uncertain times: Navigating the HeartWare HVAD recall. J Thorac Cardiovasc Surg 2022; 163 (06) 2129-2130
    CrossrefPubMedSuche in Google Scholar
  • 6 Yazdchi F, Rajab TK, Rinewalt D. et al. Comparison of heart transplant outcomes between recipients with pulsatile- vs continuous-flow LVAD. J Card Surg 2019; 34 (10) 1062-1068
    CrossrefPubMedSuche in Google Scholar
  • 7 Loforte A, Gliozzi G, Mariani C, Cavalli GG, Martin-Suarez S, Pacini D. Ventricular assist devices implantation: surgical assessment and technical strategies. Cardiovasc Diagn Ther 2021; 11 (01) 277-291
    CrossrefPubMedSuche in Google Scholar
  • 8 Lampert BC, Teuteberg JJ, Cowger J. et al. Impact of thoracotomy approach on right ventricular failure and length of stay in left ventricular assist device implants: an intermacs registry analysis. J Heart Lung Transplant 2021; 40 (09) 981-989
    CrossrefPubMedSuche in Google Scholar
  • 9 Rogers JG, Pagani FD, Tatooles AJ. et al. Intrapericardial left ventricular assist device for advanced heart failure. N Engl J Med 2017; 376 (05) 451-460
    CrossrefPubMedSuche in Google Scholar
  • 10 Mehra MR, Uriel N, Naka Y. et al; MOMENTUM 3 Investigators. A fully magnetically levitated left ventricular assist device—final report. N Engl J Med 2019; 380 (17) 1618-1627
    CrossrefPubMedSuche in Google Scholar
  • 11 Modi K, Pannu AK, Modi RJ. et al. Utilization of left ventricular assist device for congestive heart failure: inputs on demographic and hospital characterization from nationwide inpatient sample. Cureus 2021; 13 (07) e16094
    PubMedSuche in Google Scholar
  • 12 Cushing K, Kushnir V. Gastrointestinal bleeding following LVAD placement from top to bottom. Dig Dis Sci 2016; 61 (06) 1440-1447
    CrossrefPubMedSuche in Google Scholar
  • 13 Nascimbene A, Neelamegham S, Frazier OH, Moake JL, Dong JF. Acquired von Willebrand syndrome associated with left ventricular assist device. Blood 2016; 127 (25) 3133-3141
    CrossrefPubMedSuche in Google Scholar
  • 14 Roger VL. Epidemiology of heart failure: a contemporary perspective. Circ Res 2021; 128 (10) 1421-1434
    CrossrefPubMedSuche in Google Scholar
  • 15 Berardi C, Bravo CA, Li S. et al. The history of durable left ventricular assist devices and comparison of outcomes: HeartWare, HeartMate II, HeartMate 3, and the future of mechanical circulatory support. J Clin Med 2022; 11 (07) 2022
    CrossrefPubMedSuche in Google Scholar
  • 16 Lander BS, Patel K, Blackstone EH, Nordseth T, Starling RC, Gorodeski EZ. Post-acute care trajectories in the first year following hospital discharge after left ventricular assist device implantation. J Am Med Dir Assoc 2016; 17 (10) 908-912
    CrossrefPubMedSuche in Google Scholar
  • 17 Copeland H, Baran D. A persistent problem-the dreaded LVAD driveline infection. J Card Surg 2022; 37 (01) 105-106
    CrossrefPubMedSuche in Google Scholar
  • 18 Jabbar HR, Abbas A, Ahmed M. et al. The incidence, predictors and outcomes of gastrointestinal bleeding in patients with left ventricular assist device (LVAD). Dig Dis Sci 2015; 60 (12) 3697-3706
    CrossrefPubMedSuche in Google Scholar
  • 19 Harvey L, Holley C, Roy SS. et al. Stroke after left ventricular assist device implantation: outcomes in the continuous-flow era. Ann Thorac Surg 2015; 100 (02) 535-541
    CrossrefPubMedSuche in Google Scholar
  • 20 Kormos RL, McCall M, Althouse A. et al. Left ventricular assist device malfunctions: it is more than just the pump. Circulation 2017; 136 (18) 1714-1725
    CrossrefPubMedSuche in Google Scholar
  • 21 Cerier E, Lampert BC, Kilic A, McDavid A, Deo SV, Kilic A. To ventricular assist devices or not: when is implantation of a ventricular assist device appropriate in advanced ambulatory heart failure?. World J Cardiol 2016; 8 (12) 695-702
    CrossrefPubMedSuche in Google Scholar